Ideaya biosciences, inc. (IDYA)

CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19
Cash flows from operating activities
Net loss

-44,449

-41,975

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization

1,288

1,245

0

0

0

Net amortization of premiums and discounts on marketable securities

232

473

0

0

0

Stock-based compensation

2,543

2,168

0

0

0

Loss on sale of property and equipment

-13

-14

0

0

0

Gain on sales of marketable securities

9

8

0

0

0

Changes in assets and liabilities
Prepaid expenses and other assets

715

1,963

0

0

0

Right-of-use assets

-1,066

-1,093

0

0

0

Accounts payable

-473

-195

0

0

0

Accrued and other liabilities

3,141

2,030

0

0

0

Lease liabilities

-1,246

-1,249

0

0

0

Net cash used in operating activities

-39,073

-39,313

0

0

0

Cash flows from investing activities
Purchases of property and equipment, net

-

1,353

0

0

0

Purchases of marketable securities

79,931

88,004

0

0

0

Maturities of marketable securities

56,347

73,528

0

0

0

Sales of marketable securities

-

18,094

0

0

0

Net cash provided by investing activities

-12,237

2,265

0

0

0

Cash flows from financing activities
Proceeds from exercise of common stock options

322

289

0

0

0

Payments of deferred offering costs

-

-

-

-

0

Net cash provided by (used in) financing activities

51,470

50,610

0

0

0

Net increase in cash, cash equivalents and restricted cash

160

13,562

0

0

0

Supplemental disclosure of cash flow information:
Cash paid for income taxes

1

1

0

0

0

Cash paid for interest

88

91

0

0

0

Supplemental non-cash investing and financing activities:
Unpaid deferred offering costs

-

-

-

0

0

Vesting of early exercised options and restricted stock

56

114

0

0

0

Purchases of property and equipment in accounts payable and accrued liabilities

0

-

0

0

0